The activation of TRPV1 by the administration of agonists such as capsaicin and resinoxin to rodents elicits anxiety responses and depression-related behaviors, while antagonists induce anxiolytic and antidepressant-like effects in rodents [23,24,25]. This evidence concerns the gene TRPV1 and depressive symptom measurement.